The Society for Investigative Dermatology's Translational Research Grants support innovative research that bridges basic science and clinical advances in hidradenitis suppurativa.
Funder: Society for Investigative Dermatology
Due Dates: December 7, 2026 (Translational Research Grants — full application)
Funding Amounts: Up to $100,000 per year (direct costs only); two awards annually; project period: June 1, 2027 – May 31, 2028
Summary: Supports novel translational research in hidradenitis suppurativa, aiming to bridge basic discoveries and clinical applications with potential for future long-term funding.
The Translational Research Grants, promoted by the Society for Investigative Dermatology and funded through the Hidradenitis Suppurativa Foundation (HSF), support innovative research projects focused on hidradenitis suppurativa (HS). These grants specifically target translational research—projects that bridge the gap between basic scientific discoveries and clinical implementation, with the goal of moving findings closer to patient impact. The program is designed to stimulate novel ideas in HS research and to help investigators generate data that will make their work competitive for larger, long-term funding from agencies such as the NIH.